Skip to main content

Articles

Page 1 of 52

  1. A novel type of noncoding RNA, circRNA has been reported to participate in the occurrence and development of diseases through many mechanisms. The MAPK pathway is a common signal transduction pathway involved ...

    Authors: Tianlu Jiang, Yiwen Xia, Jialun Lv, Bowen Li, Ying Li, Sen Wang, Zhe Xuan, Li Xie, Shengkui Qiu, Zhongyuan He, Linjun Wang and Zekuan Xu

    Citation: Molecular Cancer 2021 20:66

    Content type: Research

    Published on:

  2. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Haihai Liang, Tong Yu, Yue Han, Hua Jiang, Chengyu Wang, Tianyi You, Xiaoguang Zhao, Huitong Shan, Rui Yang, Lida Yang, Hongli Shan and Yunyan Gu

    Citation: Molecular Cancer 2021 20:64

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2018 17:119

  3. Drug-resistance and severe side effects of chemotherapeutic agents result in unsatisfied survival of patients with lung cancer. CXCLs/CXCR2 axis plays an important role in progression of cancer including lung ...

    Authors: Yuan Cheng, Fei Mo, Qingfang Li, Xuejiao Han, Houhui Shi, Siyuan Chen, Yuquan Wei and Xiawei Wei

    Citation: Molecular Cancer 2021 20:62

    Content type: Research

    Published on:

  4. The m6A RNA methylation is the most prevalent internal modification in mammalian mRNAs which plays critical biological roles by regulating vital cellular processes. Dysregulations of the m6A modification due to a...

    Authors: Mohammad Burhan Uddin, Zhishan Wang and Chengfeng Yang

    Citation: Molecular Cancer 2021 20:61

    Content type: Review

    Published on:

  5. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Kai Han, Feng-Wei Wang, Chen-Hui Cao, Han Ling, Jie-Wei Chen, Ri-Xin Chen, Zi-Hao Feng, Jie Luo, Xiao-Han Jin, Jin-Ling Duan, Shu-Man Li, Ning-Fang Ma, Jing-Ping Yun, Xin-Yuan Guan, Zhi-Zhong Pan, Ping Lan…

    Citation: Molecular Cancer 2021 20:60

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2020 19:60

  6. Cancer cells that transit from primary tumours into the circulatory system are known as circulating tumour cells (CTCs). These cancer cells have unique phenotypic and genotypic characteristics which allow them...

    Authors: Mark P. Ward, Laura E. Kane, Lucy A. Norris, Bashir M. Mohamed, Tanya Kelly, Mark Bates, Andres Clarke, Nathan Brady, Cara M. Martin, Robert D. Brooks, Doug A. Brooks, Stavros Selemidis, Sean Hanniffy, Eric P. Dixon, Sharon A. O’Toole and John J. O’Leary

    Citation: Molecular Cancer 2021 20:59

    Content type: Review

    Published on:

  7. The landscape and characteristics of circulating exosomal messenger RNAs (emRNAs) are poorly understood, which hampered the accurate detection of circulating emRNAs. Through comparing RNA sequencing data of ci...

    Authors: Jin Ji, Rui Chen, Lin Zhao, Yalong Xu, Zhi Cao, Huan Xu, Xi Chen, Xiaolei Shi, Yasheng Zhu, Ji Lyu, Junfeng Jiang, Yue Wang, Tie Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu…

    Citation: Molecular Cancer 2021 20:58

    Content type: Letter to the Editor

    Published on:

  8. Endometrial cancer (EC) is a major cause of death among gynecologic malignancies. To improve early detection of EC in patients, we carried out a large plasma-derived exosomal microRNA (miRNA) studies for diagn...

    Authors: Lanyun Zhou, Wei Wang, Fenfen Wang, Siqi Yang, Jiaqi Hu, Bingjian Lu, Zimin Pan, Yu Ma, Mengyue Zheng, Liyuan Zhou, Shufeng Lei, Penghong Song, Pengyuan Liu, Weiguo Lu and Yan Lu

    Citation: Molecular Cancer 2021 20:57

    Content type: Letter to the Editor

    Published on:

  9. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Yan Xu, Yuan Li, Jiankang Jin, Guangchun Han, Chengcao Sun, Melissa Pool Pizzi, Longfei Huo, Ailing Scott, Ying Wang, Lang Ma, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Christopher Vellano, Liuqing Yang, Chunru Lin…

    Citation: Molecular Cancer 2021 20:56

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2019 18:141

  10. As a complement to the clinical development of new anticancer molecules, innovations in therapeutic vectorization aim at solving issues related to tumor specificity and associated toxicities. Nanomedicine is a...

    Authors: Tina Briolay, Tacien Petithomme, Morgane Fouet, Nelly Nguyen-Pham, Christophe Blanquart and Nicolas Boisgerault

    Citation: Molecular Cancer 2021 20:55

    Content type: Review

    Published on:

  11. Lung cancer (LC) is a heterogeneous disease consisting mainly of two subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and remains the leading cause of death worldwide. Despite re...

    Authors: Parvez Khan, Jawed Akhtar Siddiqui, Imayavaramban Lakshmanan, Apar Kishor Ganti, Ravi Salgia, Maneesh Jain, Surinder Kumar Batra and Mohd Wasim Nasser

    Citation: Molecular Cancer 2021 20:54

    Content type: Review

    Published on:

  12. A growing number of studies have focused on investigating circRNAs as crucial regulators in the progression of multiple cancer types. Nevertheless, the biological effects and underlying mechanisms of circRNAs ...

    Authors: Peng Shen, Taoyue Yang, Qun Chen, Hao Yuan, Pengfei Wu, Baobao Cai, Lingdong Meng, Xumin Huang, Jiaye Liu, Yihan Zhang, Weikang Hu, Yi Miao, Zipeng Lu and Kuirong Jiang

    Citation: Molecular Cancer 2021 20:51

    Content type: Research Article

    Published on:

  13. Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by ...

    Authors: Yiyang Zheng, Yanyan Luo, Xixi Chen, Huiting Li, Baojun Huang, Baofeng Zhou, Liqing Zhu, Xianhui Kang and Wujun Geng

    Citation: Molecular Cancer 2021 20:49

    Content type: Review

    Published on:

  14. mRNA therapeutics have become the focus of molecular medicine research. Various mRNA applications have reached major milestones at high speed in the immuno-oncology field. This can be attributed to the knowled...

    Authors: Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot and Sandra Van Lint

    Citation: Molecular Cancer 2021 20:48

    Content type: Review

    Published on:

  15. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Jingfeng Zhou, Shenglan Liu, Yun Wang, Wei Dai, Hailin Zou, Shubo Wang, Jing Zhang and Jingxuan Pan

    Citation: Molecular Cancer 2021 20:47

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2019 18:159

  16. Hepatocellular carcinoma (HCC) is among the malignancies with the highest mortality. The key regulators and their interactive network in HCC pathogenesis remain unclear. Along with genetic mutations, aberrant ...

    Authors: Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, Qingling Fan, Jie Hu, Lintao Jia and Lei Liu

    Citation: Molecular Cancer 2021 20:46

    Content type: Research

    Published on:

  17. The tumor suppressor FBW7 is the substrate recognition component of the SCF E3-ubiquitin ligase complex that mediates proteolytic degradation of various oncogenic proteins. However, the role of FBW7 in ovarian...

    Authors: Fei Xu, Jiajia Li, Mengdong Ni, Jingyi Cheng, Haiyun Zhao, Shanshan Wang, Xiang Zhou and Xiaohua Wu

    Citation: Molecular Cancer 2021 20:45

    Content type: Research

    Published on:

  18. Chemotherapeutic resistance is the main cause of clinical treatment failure and poor prognosis in triple-negative breast cancer (TNBC). There is no research on chemotherapeutic resistance in TNBC from the pers...

    Authors: Lei Wang, Yehui Zhou, Liang Jiang, Linlin Lu, Tiantian Dai, Aoshuang Li, Yan Chen and Lifeng Zhang

    Citation: Molecular Cancer 2021 20:43

    Content type: Research

    Published on:

  19. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Xiao Zheng, Lujun Chen, You Zhou, Qi Wang, Zhuojun Zheng, Bin Xu, Chen Wu, Qi Zhou, Wenwei Hu, Changping Wu and Jingting Jiang

    Citation: Molecular Cancer 2021 20:42

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2019 18:47

  20. mRNA vaccines have become a promising platform for cancer immunotherapy. During vaccination, naked or vehicle loaded mRNA vaccines efficiently express tumor antigens in antigen-presenting cells (APCs), facilit...

    Authors: Lei Miao, Yu Zhang and Leaf Huang

    Citation: Molecular Cancer 2021 20:41

    Content type: Review

    Published on:

  21. DNA and RNA can fold into a variety of alternative conformations. In recent years, a particular nucleic acid structure was discussed to play a role in malignant transformation and cancer development. This stru...

    Authors: Nils Kosiol, Stefan Juranek, Peter Brossart, Annkristin Heine and Katrin Paeschke

    Citation: Molecular Cancer 2021 20:40

    Content type: Review

    Published on:

  22. The DEAD-box helicase family member DDX3X (DBX, DDX3) functions in nearly all stages of RNA metabolism and participates in the progression of many diseases, including virus infection, inflammation, intellectua...

    Authors: Jie Mo, Huifang Liang, Chen Su, Pengcheng Li, Jin Chen and Bixiang Zhang

    Citation: Molecular Cancer 2021 20:38

    Content type: Review

    Published on:

  23. Early detection is crucial to improve breast cancer (BC) patients’ outcomes and survival. Mammogram and ultrasound adopting the Breast Imaging Reporting and Data System (BI-RADS) categorization are widely used...

    Authors: Jiaqi Liu, Hengqiang Zhao, Yukuan Huang, Shouping Xu, Yan Zhou, Wei Zhang, Jiaqi Li, Yue Ming, Xinyu Wang, Sen Zhao, Kai Li, Xiying Dong, Yunlong Ma, Tianyi Qian, Xinyi Chen, Zeyu Xing…

    Citation: Molecular Cancer 2021 20:36

    Content type: Letter to the Editor

    Published on:

  24. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Feng Wei, Chengyuan Ma, Tong Zhou, Xuechao Dong, Qinghua Luo, Li Geng, Lijuan Ding, Yandong Zhang, Li Zhang, Nan Li, Yang Li and Yan Liu

    Citation: Molecular Cancer 2021 20:35

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2017 16:132

  25. mRNA vaccines have tremendous potential to fight against cancer and viral diseases due to superiorities in safety, efficacy and industrial production. In recent decades, we have witnessed the development of di...

    Authors: Yang Wang, Ziqi Zhang, Jingwen Luo, Xuejiao Han, Yuquan Wei and Xiawei Wei

    Citation: Molecular Cancer 2021 20:33

    Content type: Review

    Published on:

  26. In the “precision oncology” era the characterization of tumor genetic features is a pivotal step in cancer patients’ management. Liquid biopsy approaches, such as analysis of cell-free DNA from plasma, represe...

    Authors: Filippo Martignano, Uday Munagala, Stefania Crucitta, Alessandra Mingrino, Roberto Semeraro, Marzia Del Re, Iacopo Petrini, Alberto Magi and Silvestro G. Conticello

    Citation: Molecular Cancer 2021 20:32

    Content type: Letter to the Editor

    Published on:

  27. The characterization of circulating tumor cells (CTCs) holds promises for precision medicine because these cells are an important clinical indicator of treatment efficacy. We established the first and still on...

    Authors: Laure Cayrefourcq, Frédéric Thomas, Thibault Mazard, Eric Assenat, Said Assou and Catherine Alix-Panabières

    Citation: Molecular Cancer 2021 20:30

    Content type: Letter to the Editor

    Published on:

  28. The four major RNA adenosine modifications, i.e., m6A, m1A, alternative polyadenylation, and adenosine-to-inosine RNA editing, are mediated mostly by the “writer” enzymes and constitute critical mechanisms of epi...

    Authors: Huifang Chen, Jiameng Yao, Rujuan Bao, Yu Dong, Ting Zhang, Yanhua Du, Gaoyang Wang, Duan Ni, Zhenzhen Xun, Xiaoyin Niu, Youqiong Ye and Hua-Bing Li

    Citation: Molecular Cancer 2021 20:29

    Content type: Research

    Published on:

  29. The overlapping metabolic reprogramming of cancer and immune cells is a putative determinant of the antitumor immune response in cancer. Increased evidence suggests that cancer metabolism not only plays a cruc...

    Authors: Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Yaqian Han, Nayiyuan Wu, Pin Yi, Lu Tang, Qing Pan, Shan Rao, Jiaxin Liang, Yanyan Tang, Min Su, Xia Luo, Yiqing Yang, Yingrui Shi…

    Citation: Molecular Cancer 2021 20:28

    Content type: Review

    Published on:

  30. The development of immune checkpoint blockade (ICB)-based immunotherapy has dramatically changed methods of cancer treatment. This approach triggers a durable treatment response and prolongs patients' survival...

    Authors: Jun-Yan Li, Yu-Pei Chen, Ying-Qin Li, Na Liu and Jun Ma

    Citation: Molecular Cancer 2021 20:27

    Content type: Review

    Published on:

  31. Colorectal cancer (CRC) is a common hereditary tumor that is often fatal. Its pathogenesis involves multiple genes, including circular RNAs (circRNAs). Notably, circRNAs constitute a new class of noncoding RNA...

    Authors: Fei Long, Zhi Lin, Liang Li, Min Ma, Zhixing Lu, Liang Jing, Xiaorong Li and Changwei Lin

    Citation: Molecular Cancer 2021 20:26

    Content type: Review

    Published on:

  32. E3 ubiquitin ligase HRD1 (HMG-CoA reductase degradation protein 1, alias synoviolin with SYVN1 as the official gene symbol) was found downregulated and acting as a tumor suppressor in breast cancer, while the ...

    Authors: Ya Fan, Jia Wang, Wen Jin, Yifei Sun, Yuemei Xu, Yipin Wang, Xiubin Liang and Dongming Su

    Citation: Molecular Cancer 2021 20:25

    Content type: Research

    Published on:

  33. Noncoding RNA (ncRNA) transcripts that did not code proteins but regulate their functions were extensively studied for the last two decades and the plethora of discoveries have instigated scientists to investi...

    Authors: Swati Mohapatra, Carlotta Pioppini, Bulent Ozpolat and George A. Calin

    Citation: Molecular Cancer 2021 20:24

    Content type: Review

    Published on:

  34. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto and Robert Ballotti

    Citation: Molecular Cancer 2021 20:21

    Content type: Correction

    Published on:

    The original article was published in Molecular Cancer 2021 20:12

  35. Hepatocellular carcinoma (HCC) is one of the most common human malignancies worldwide with very poor prognosis. Resistance to targeted therapeutic drugs such as sorafenib remains one of the major challenges in...

    Authors: Xiao-Dong Yang, Fan-En Kong, Ling Qi, Jia-Xin Lin, Qian Yan, Jane Ho Chun Loong, Shao-Yan Xi, Yue Zhao, Yan Zhang, Yun-Fei Yuan, Ning-Fang Ma, Stephanie Ma, Xin-Yuan Guan and Ming Liu

    Citation: Molecular Cancer 2021 20:20

    Content type: Letter to the Editor

    Published on:

  36. There is increasing evidence that circular RNAs (circRNAs) have significant regulatory roles in cancer development and progression; however, the expression patterns and biological functions of circRNAs in rena...

    Authors: Junjie Cen, Yanping Liang, Yong Huang, Yihui Pan, Guannan Shu, Zhousan Zheng, Xiaozhong Liao, Mi Zhou, Danlei Chen, Yong Fang, Wei Chen, Junhang Luo and Jiaxing Zhang

    Citation: Molecular Cancer 2021 20:19

    Content type: Research

    Published on:

  37. Epidermal growth factor receptor (EGFR)-mutated lung cancer constitutes a major subgroup of non-small cell lung cancer (NSCLC) and osimertinib is administrated as first-line treatment. However, most patients w...

    Authors: Shaocong Wu, Min Luo, Kenneth K. W. To, Jianye Zhang, Chaoyue Su, Hong Zhang, Sainan An, Fang Wang, Da Chen and Liwu Fu

    Citation: Molecular Cancer 2021 20:17

    Content type: Research

    Published on:

Annual Journal Metrics

\